Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker AnalysesJung Min Lee, Elise C. Kohn, William D. Figg et al.|JNCI Journal of the National Cancer Institute|2014Cited by 184
Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's CancerJung Min Lee, Elise C. Kohn, Cody J. Peer et al.|Clinical Cancer Research|2016Cited by 59
Phase I/Ib study of olaparib and carboplatin in women with triple negative breast cancerJung Min Lee, Elise C. Kohn, John L. Hays et al.|Oncotarget|2017Cited by 43
Feasibility and safety of sequential research‐related tumor core biopsies in clinical trialsJung Min Lee, Elise C. Kohn, John L. Hays et al.|Cancer|2012Cited by 33
Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancerJung Min Lee, Elise C. Kohn, Nicolas Gordon et al.|Journal of Translational Medicine|2015Cited by 17